Babafemi Taiwo, MD
Enriched profileGene Stollerman Professor of Medicine and Chief of the Division of Infectious Diseases · Northwestern University Feinberg School of Medicine
Babafemi Taiwo is Gene Stollerman Professor of Medicine and Chief of the Division of Infectious Diseases at Northwestern University Feinberg School of Medicine. OpenAlex indexes 232 publications with 7,506 citations (h-index 39); ClinicalTrials.gov lists 6 registered studies with this person as an investigator.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Babafemi Taiwo, MD, is Gene Stollerman Professor of Medicine and Chief of the Division of Infectious Diseases at Northwestern University Feinberg School of Medicine. The public record shows 232 publications with 7,506 citations (h-index 39), centered on HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, HIV Research and Treatment. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 7 companies, 7 NIH-funded awards (2013–2023).
- Most recent indexed publication: 2025 · JMIR formative research
- Top research focus: HIV/AIDS Research and Interventions
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 119.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- Intensive Combination Approach to Rollback the Epidemic in Nigerian Adolescents: UH3 Phase
Sponsor: Northwestern University
- Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Dolutegravir Plus Lamivudine Dual Therapy in Treatment Naïve HIV-1 Patients
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Industry payments
Updated 18 Oct 2026
7 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year202418 payments$18,018openpaymentsdata.cms.gov ↗
- ViiV Healthcare CompanyProgram year202334 payments$52,505openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year20235 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
76%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor41%Dovato62%Tivicay38%Part D<11 patientsProtease Inhibitor11.1%Symtuza56%Prezcobix44%Part D<11 patients+ 6 more classes in this area
Cardiovascular
20.6%Statin16%Rosuvastatin Calcium68%Atorvastatin Calcium32%Part D<11 patientsCalcium channel blocker4.6%Amlodipine Besylate100%Part D<11 patientsGenitourinary & hormones
3.4%Androgen3.4%Testosterone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
7 NIH research awards on record, funded 2013–2023 per NIH RePORTER. The latest:
- Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness / Implementation Hybrid Study
Northwestern University at Chicago
FY2023$1,410,220UG1HD113160
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- iTRAIN During iCARE Nigeria: Virtual Implementation Research Training Course Nested Within an Ongoing Trial.
Global implementation research and applications
Article2025
Most-cited works
by citation count (OpenAlex)- 01Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19Article1,836 citations2020
- 02HIVArticle307 citations2018
- 03
- 04HIV infectionReview242 citations2023
- 05The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillanceArticle179 citations2022
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →com.ui.edu.ng ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →news.feinberg.northwestern.edu ↗
Editorial & leadership roles
journal and society appointments- Editor
HIV Section of Journal of Antimicrobial Chemotherapy
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →com.ui.edu.ng ↗ - Former Editor
AIDS Research and Human Retroviruses
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →news.feinberg.northwestern.edu ↗ - Member
Executive Committee of AIDS Clinical Trials Group
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →com.ui.edu.ng ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.feinberg.northwestern.edu ↗
Secondary affiliations
appointments beyond the home institution- Director
CFAR Clinical Sciences Core
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →thirdcoastcfar.org ↗ - Director
Clinical Sciences Core at Third Coast Center for AIDS Research
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →thirdcoastcfar.org ↗ - Director for African Research
Center for Global Health at Northwestern University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.feinberg.northwestern.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University Feinberg School of Medicine
Martin Tallman, MD
Northwestern University Feinberg School of Medicine
Al Benson, MD
Northwestern University Feinberg School of Medicine
Sanjiv Shah, MD
Northwestern University Feinberg School of Medicine
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital